BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 24100332)

  • 1. Structures of oncogenic, suppressor and rescued p53 core-domain variants: mechanisms of mutant p53 rescue.
    Wallentine BD; Wang Y; Tretyachenko-Ladokhina V; Tan M; Senear DF; Luecke H
    Acta Crystallogr D Biol Crystallogr; 2013 Oct; 69(Pt 10):2146-56. PubMed ID: 24100332
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular mechanisms of functional rescue mediated by P53 tumor suppressor mutations.
    Tan YH; Chen YM; Ye X; Lu Q; Tretyachenko-Ladokhina V; Yang W; Senear DF; Luo R
    Biophys Chem; 2009 Nov; 145(1):37-44. PubMed ID: 19748724
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Crystal structure of a superstable mutant of human p53 core domain. Insights into the mechanism of rescuing oncogenic mutations.
    Joerger AC; Allen MD; Fersht AR
    J Biol Chem; 2004 Jan; 279(2):1291-6. PubMed ID: 14534297
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural basis of restoring sequence-specific DNA binding and transactivation to mutant p53 by suppressor mutations.
    Suad O; Rozenberg H; Brosh R; Diskin-Posner Y; Kessler N; Shimon LJ; Frolow F; Liran A; Rotter V; Shakked Z
    J Mol Biol; 2009 Jan; 385(1):249-65. PubMed ID: 18996393
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural effects of the L145Q, V157F, and R282W cancer-associated mutations in the p53 DNA-binding core domain.
    Calhoun S; Daggett V
    Biochemistry; 2011 Jun; 50(23):5345-53. PubMed ID: 21561095
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural basis for understanding oncogenic p53 mutations and designing rescue drugs.
    Joerger AC; Ang HC; Fersht AR
    Proc Natl Acad Sci U S A; 2006 Oct; 103(41):15056-61. PubMed ID: 17015838
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanism of rescue of common p53 cancer mutations by second-site suppressor mutations.
    Nikolova PV; Wong KB; DeDecker B; Henckel J; Fersht AR
    EMBO J; 2000 Feb; 19(3):370-8. PubMed ID: 10654936
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structures of p53 cancer mutants and mechanism of rescue by second-site suppressor mutations.
    Joerger AC; Ang HC; Veprintsev DB; Blair CM; Fersht AR
    J Biol Chem; 2005 Apr; 280(16):16030-7. PubMed ID: 15703170
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insights into Allosteric Mechanisms of the Lung-Enriched p53 Mutants V157F and R158L.
    Lei J; Li X; Cai M; Guo T; Lin D; Deng X; Li Y
    Int J Mol Sci; 2022 Sep; 23(17):. PubMed ID: 36077492
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An in silico algorithm for identifying stabilizing pockets in proteins: test case, the Y220C mutant of the p53 tumor suppressor protein.
    Bromley D; Bauer MR; Fersht AR; Daggett V
    Protein Eng Des Sel; 2016 Sep; 29(9):377-90. PubMed ID: 27503952
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hot-spot mutants of p53 core domain evince characteristic local structural changes.
    Wong KB; DeDecker BS; Freund SM; Proctor MR; Bycroft M; Fersht AR
    Proc Natl Acad Sci U S A; 1999 Jul; 96(15):8438-42. PubMed ID: 10411893
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural studies of p53 inactivation by DNA-contact mutations and its rescue by suppressor mutations via alternative protein-DNA interactions.
    Eldar A; Rozenberg H; Diskin-Posner Y; Rohs R; Shakked Z
    Nucleic Acids Res; 2013 Oct; 41(18):8748-59. PubMed ID: 23863845
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stabilising the DNA-binding domain of p53 by rational design of its hydrophobic core.
    Khoo KH; Joerger AC; Freund SM; Fersht AR
    Protein Eng Des Sel; 2009 Jul; 22(7):421-30. PubMed ID: 19515728
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitative analysis of residual folding and DNA binding in mutant p53 core domain: definition of mutant states for rescue in cancer therapy.
    Bullock AN; Henckel J; Fersht AR
    Oncogene; 2000 Mar; 19(10):1245-56. PubMed ID: 10713666
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kinetic instability of p53 core domain mutants: implications for rescue by small molecules.
    Friedler A; Veprintsev DB; Hansson LO; Fersht AR
    J Biol Chem; 2003 Jun; 278(26):24108-12. PubMed ID: 12700230
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factors governing loss and rescue of DNA binding upon single and double mutations in the p53 core domain.
    Wright JD; Noskov SY; Lim C
    Nucleic Acids Res; 2002 Apr; 30(7):1563-74. PubMed ID: 11917017
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thermodynamic stability of wild-type and mutant p53 core domain.
    Bullock AN; Henckel J; DeDecker BS; Johnson CM; Nikolova PV; Proctor MR; Lane DP; Fersht AR
    Proc Natl Acad Sci U S A; 1997 Dec; 94(26):14338-42. PubMed ID: 9405613
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of stability on the biological function of p53.
    Khoo KH; Mayer S; Fersht AR
    J Biol Chem; 2009 Nov; 284(45):30974-80. PubMed ID: 19700401
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ensemble-based computational approach discriminates functional activity of p53 cancer and rescue mutants.
    Demir Ö; Baronio R; Salehi F; Wassman CD; Hall L; Hatfield GW; Chamberlin R; Kaiser P; Lathrop RH; Amaro RE
    PLoS Comput Biol; 2011 Oct; 7(10):e1002238. PubMed ID: 22028641
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure-function-rescue: the diverse nature of common p53 cancer mutants.
    Joerger AC; Fersht AR
    Oncogene; 2007 Apr; 26(15):2226-42. PubMed ID: 17401432
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.